Stage 4 lung cancer survivor: Why I joined a targeted therapy clinical trial at UT MD Anderson
I work in the pharmaceutical industry with a drug that treats Parkinson’s disease symptoms, so I’m familiar with the drug-vetting process. Just because a drug hasn’t been approved yet by the Food and Drug Administration (FDA) doesn’t necessarily mean it’s not safe or effective — it just means it’s still being studied in anticipation of approval.
So, when my UT MD Anderson thoracic medical oncologist, Dr. Eric Singhi, offered me...
